GH
$54.87
Revenue | $232.09Mn |
Net Profits | $-99.9Mn |
Net Profit Margins | -43.04% |
Guardant Health, Inc.’s revenue jumped 30.95% since last year same period to $232.09Mn in the Q2 2025. On a quarterly growth basis, Guardant Health, Inc. has generated 14.06% jump in its revenue since last 3-months.
Guardant Health, Inc.’s net profit jumped 2.66% since last year same period to $-99.9Mn in the Q2 2025. On a quarterly growth basis, Guardant Health, Inc. has generated -4.98% fall in its net profits since last 3-months.
Guardant Health, Inc.’s net profit margin jumped 25.67% since last year same period to -43.04% in the Q2 2025. On a quarterly growth basis, Guardant Health, Inc. has generated 7.96% jump in its net profit margins since last 3-months.
EPS Estimate Current Quarter | -0.79 |
EPS Estimate Current Year | -0.79 |
Guardant Health, Inc.’s earning per share (EPS) estimates for the current quarter stand at -0.79 - a -9.19% fall from last quarter’s estimates.
Guardant Health, Inc.’s earning per share (EPS) estimates for the current year stand at -0.79.
Earning Per Share (EPS) | 0 |
Guardant Health, Inc.’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q3 2025. This indicates that the Guardant Health, Inc. has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2025-07-30 | -0.72 | -0.44 | 38.89% |
2025-10-30 | -0.79 | 0 | 100% |
2025-04-30 | -0.85 | -0.49 | 42.35% |